EUVIMEDEUVIMED entdecken
Crossref

Nonalcoholic Fatty Liver Disease Is Independently Associated With Higher All-Cause and Cause-Specific Mortality

Leyla de Avila, Linda Henry, James M Paik, Naila Ijaz, Ali A Weinstein, Zobair M Younossi

Clinical Gastroenterology and Hepatology · 2023-09 · 21 (10) · 2588-2596.e3

DOI: 10.1016/j.cgh.2023.01.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-09. Verfasst von Leyla de Avila und 5 weiteren Autor:innen. Beteiligte Einrichtung: Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing globally. We assessed independent associations of NAFLD with all-cause and cause-specific mortality in older community-dwelling adults in the United States. METHODS: Data from the Rancho Bernardo Study cohort, who participated in the research from 1992 to 1996 with mortality data (followed up to July 2019), were analyzed. NAFLD was determined by the improved Fatty Liver Index for the multiethnic US population in the absence of secondary causes of liver disease. Hazard ratios (HRs), 95% CIs, and population-attributable fractions of risk factors on mortality were calculated. Competing-risk analyses of cause-specific mortality were performed. RESULTS: Of the 1523 eligible participants (mean age, 71.8 y; 39.9% male; 99.3% non-Hispanic White; and 10.7% obese), 404 (26.4%) had NAFLD. During 23,311 person-years of follow-up evaluation (mean, 15.22 y; SD, 8.41 y), among NAFLD and non-NAFLD, there were 296 and 717 deaths from all causes, 113 and 263 cardiac deaths, 62 and 112 cancer deaths, and 6 and 2 liver deaths, respectively. NAFLD had a 26% higher all-cause mortality (HR, 1.26; 95% CI, 1.08-1.47) and a 33% (HR, 1.33; 95% CI, 1.04-1.70) and 55% (HR, 1.55; 95% CI, 1.11-2.15) higher cardiac and cancer mortality, respectively, than non-NAFLD. Population-attributable fractions showed 13.9% of deaths, 6.2% of cardiac deaths, and 12.1% of cancer deaths were attributable to NAFLD after adjustments of risk factors (sedentary lifestyle, obesity, hypertension, hyperlipidemia, diabetes). CONCLUSIONS: NAFLD is associated independently with all-cause, cardiac, and cancer mortality. Efforts must continue to raise awareness about NAFLD and develop care pathways and public health efforts to reduce NAFLD burden and associated mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseNeoplasmsAdultHumansMaleUnited StatesAgedFemaleCause of DeathRisk FactorsObesity

Stichwörter der Autor:innen

HypertensionObesityPAFSedentary Behavior

Autor:innen und Institutionen

  • Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia.
  • Center for Outcomes Research in Liver Diseases, Washington, District of Columbia.
  • Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia; Department of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, Virgin…
  • Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia.
  • Department of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, Virginia.
  • Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia; Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia. Electronic addres…

Zitieren

APA

de Avila, L., Henry, L., Paik, J. M., Ijaz, N., Weinstein, A. A., & Younossi, Z. M. (2023). Nonalcoholic Fatty Liver Disease Is Independently Associated With Higher All-Cause and Cause-Specific Mortality. Clinical Gastroenterology and Hepatology, 21(10), 2588-2596.e3. https://doi.org/10.1016/j.cgh.2023.01.006

Vancouver

de Avila L, Henry L, Paik JM, Ijaz N, Weinstein AA, Younossi ZM. Nonalcoholic Fatty Liver Disease Is Independently Associated With Higher All-Cause and Cause-Specific Mortality. Clinical Gastroenterology and Hepatology. 2023;21(10):2588-2596.e3. doi:10.1016/j.cgh.2023.01.006

BibTeX
@article{deAvila2023,
  author = {de Avila, Leyla and Henry, Linda and Paik, James M and Ijaz, Naila and Weinstein, Ali A and Younossi, Zobair M},
  title = {Nonalcoholic Fatty Liver Disease Is Independently Associated With Higher All-Cause and Cause-Specific Mortality},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {10},
  pages = {2588--2596.e3},
  doi = {10.1016/j.cgh.2023.01.006}
}
Kostenlos starten →